Recent Headlines
Within Pharmaceuticals
Purity Health, LLC Announces Lora Harnack as New Chief Executive Officer
Purity Health, LLC has appointed Lora Harnack as its new Chief Executive Officer, with former CEO Rob Bramblett transitioning to President. Harnack, a Tennessee native with 30 years of healthcare leadership experience, has held executive roles in hospital administration, healthcare IT, and nonprofit organizations, most recently leading the Cumberland Pediatric Foundation. - February 21, 2025 - Purity Health, LLC
PathogenDx Launches Its Rebranded D3 Array™ Combined, Bacterial and Fungal Assays—Delivering Value in Turn-Around Time, Cost and Throughput to Testing Labs
PathogenDx, a leader in next-generation microarray technology for better health and safety, announced the launch of its new rebranded D3 Array™ Combined, Bacterial and Fungal assays to replace Detectx–Combined,Detectx-Bacterial and Detectx-Fungal tests. - February 20, 2025 - PathogenDx, Inc.
Two Peoria Residents Win $20,000 in National Transformation Contest
Wayne Galpin and Kaitlyn Willis of FXB Peoria have won the 2024 Farrell’s National Challenge, each earning $10,000 for their remarkable yearlong fitness transformations. Farrell’s eXtreme Bodyshaping (FXB) combines kickboxing, strength training, nutrition coaching, and accountability to help members achieve lasting health results. Their dedication not only transformed their lives but also inspired their community. - February 19, 2025 - Farrell's Extreme Body Shaping
New Book "Messy Mind, Brilliant Life" Empowers ADHD Individuals to Thrive; Dr. Heather Wisdom’s Guide to Unlocking the Power of the ADHD Brain
Author and podcast host Dr. Heather Wisdom announces the release of Messy Mind, Brilliant Life: A Practical Guide to Thriving with ADD/ADHD. This book reframes ADHD as a unique way of thinking rather than a deficit and offers strategies for harnessing its strengths. - February 19, 2025 - Dr. Heather Wisdom
Health Response Alliance Launched to Unify Disaster Response Efforts Across Sectors
Health Response Alliance (HRA) unites public, private, and nonprofit partners to strengthen disaster response. Led by CEO Tom Cotter, HRA streamlines resource-sharing and coordination, emphasizing cross-sector collaboration and early-stage crisis intervention. With evolving federal policies, HRA fills gaps by fostering cooperation among health agencies and other key stakeholders, ensuring communities receive timely, equitable, and effective support during emergencies. - February 19, 2025 - Health Response Alliance
Young Adults with Special Needs Face Critical Gap in Support Services; Samantha's Outings Provides Vital Community Resource
There's a void in aid once children with special needs become adults, Samantha's Outings aims to fill that void. - February 18, 2025 - Samantha's Outings
NuvOx Announces MHRA Approval to Commence Phase IIb Stroke Trial
NuvOx Therapeutics, Inc. (“NuvOx”) announced that The Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom in collaboration with the Research Ethics Committee has accepted the amended request for a clinical trial authorisation (CTA). This acceptance will... - February 14, 2025 - NuvOx Therapeutics
Tricerat Names New CEO and Launches New ScrewDrivers® for Next-Gen Print Management
Tricerat, the industry-leading print management software since 1997, appoints Hannah Shuman as President & CEO. New leadership also comes with a new product: ScrewDrivers® 7.8.0 adds more granular permissions, ARM64 compatibility, and expanded support for secure printing in complex desktop, VDI, cloud, and hybrid setups. - February 12, 2025 - Tricerat
Biovenic Scripts a New Chapter to Boom Veterinary Diagnostics
Biovenic, a powerhouse in veterinary research, transforms the way to detect and manage animal diseases, spotlighting innovative animal disease diagnostic solutions that answer the rising demand for exact and precise veterinary diagnostics worldwide. - February 12, 2025 - Biovenic
expEDIum Announces the Launch of expEDIum Office EHR
expEDIum announces the Q2 2025 launch of expEDIum Office EHR, a gastroenterology-focused EHR designed to streamline workflows, enhance patient care, and ensure compliance with industry standards. - February 08, 2025 - expEDIum
Legacy Pharma Inc. SEZC Announces the Acquisition of InterMune, Inc. and the U.S. Rights to Esbriet® from Genentech a Member of the Roche Group
Legacy Pharma Inc. SEZC (“Legacy Pharma” or the “Company”), a specialty pharmaceutical company, announced the completion of the acquisition of InterMune, Inc. (“InterMune”) and the intellectual property rights to Esbriet® (pirfenidone) in the United States... - February 06, 2025 - Legacy Pharma Inc. SEZC
Solution Group Partners with 424 Capital to Accelerate Growth and Expand Service Offering
Solution Group, a leading provider of water and wastewater services, consulting, and technology announced today that it has secured a strategic investment from 424 Capital to accelerate growth and expand its service offering. This partnership marks a significant milestone in Solution Group’s history, allowing the Company to continue its recent growth and provide additional value to clients. - February 03, 2025 - Solution Group
Rajesh (Raj) B. Shah Joins CR&T Board of Directors to Advance Cancer Research and Treatment
The Cancer Research & Treatment Fund, Inc. (CR&T) proudly announces the appointment of Rajesh (Raj) B. Shah to its esteemed Board of Directors. Raj brings a wealth of experience and passion to CR&T’s mission of advancing the fight against cancer. His appointment reinforces the... - January 29, 2025 - The Cancer Research & Treatment Fund, Inc.
Hemanext Announces Close of Series B-2 Equity Funding Round
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, announces close of series B-2 equity fundraising round. The B-2 fundraising was launched in May 2024 to raise $16-20 million and was completed in October 2024, raising just over $20 million at a pre-money... - January 27, 2025 - Hemanext
African Mission Healthcare Awards Dr. Gregory Sund the $500,000 L'Chaim Prize Which Will Improve Rural Healthcare for Women and Children in Africa
African Mission Healthcare is privileged to announce Dr. Gregory Sund, MD, FCA, as the recipient of the Gerson L'Chaim Prize for Outstanding Christian Medical Service. This prestigious $500,000 award, the largest annual award dedicated to direct medical care, is granted to Dr. Sund and his institution to implement a transformative proposal aimed at enhancing anesthesia care in East Africa. The project will focus on safe anesthesia, benefiting women and children's health in under-resourced areas. - January 22, 2025 - African Mission Healthcare
DDi Released New ViSU eIFU Version for Medical Device Companies
DDi has launched an updated version of its ViSU eIFU platform, designed for medical device manufacturers to transition from traditional paper instructions to electronic formats. The platform supports regulatory compliance with global standards, including the EU MDR and FDA, while providing multi-language accessibility and an enhanced user experience. - January 17, 2025 - DDi LLC
Purple Diamond Hosting Exclusive Webinar on Pharmaceutical Packaging Validation and Product Integrity
Purple Diamond, a leading ISO-accredited package testing lab, will host a free webinar on February 4, at 2 pm EST. "Protecting Pharma Integrity: The Science of Packaging Validation" will provide insights into testing methodologies and tools critical for ensuring pharmaceutical packaging safety and compliance. - January 16, 2025 - Purple Diamond Testing
Bench International Celebrates 50 Years of Transforming Life Sciences Leadership
Bench International, the longest-serving woman-founded executive search firm in life sciences, is proud to celebrate its 50th Anniversary, marking five decades of shaping transformative leadership in the industry. This milestone will be commemorated at a special gala event next week in San... - January 10, 2025 - Bench International
Operation Dream Landing Launches: Empowering Undecided with Industry Awareness and Dream Career Pathways
Dream2Career today announced the launch of Operation Dream Landing, a collaborative media project designed to empower undecided students and career seekers with the reliable information and resources they need to define their pathway to success. Dream2Career is actively seeking experts to join this unified talent marketing project. - January 10, 2025 - Dream2Career
Conigen Bioscience and North Star Scientific, Inc. Partner to Broaden Access to Next-Generation Dimeric-Specific Epitope Tool-Molecules, Empowering Drug Discovery
Conigen Bioscience, Inc., based in Worcester, Massachusetts, has partnered with North Star Scientific, Inc. to expand access to its transformative protein tools across North America. Conigen pioneers innovations in bioactive conformational soluble dimer proteins and membrane proteins displayed on... - January 07, 2025 - Conigen Bioscience, Inc
Physicians Research Group and bioaccess® Join Forces to Expand Clinical Trial Opportunities in South America
Physicians Research Group (PRG), a leading clinical trial site network and bioaccess®, Latin America’s premier contract research organization (CRO), are proud to announce a strategic collaboration aimed at advancing clinical research and increasing access to innovative treatments across South America. - January 07, 2025 - Physicians Research Group
Ales for ALS Achieves $1 Million Milestone and Expands Nationwide
Ales for ALS™, a global initiative uniting craft breweries in the fight against ALS, has reached an extraordinary milestone in 2024: raising $1 million in a single year. Supported by Yakima Chief Hops, this program has seen remarkable growth over its 13-year journey, fueled by the dedication of brewers, sponsors, and a passionate community. - January 06, 2025 - ALS Therapy Development Institute
New GCP Course in Spanish Language
Pharma Lessons Ltd has launched a brand new GCP training in Spanish language. The course is actually a translated version of the International Good Clinical Practice training course of the company. It keeps the same structure and beautifully designed and user friendly content. The course includes... - December 31, 2024 - Pharma Lessons
Hemanext Inc. Announces First Patients Treated in a Clinical Trial Investigating the Efficacy of the Hemanext ONE® Red Blood Cell Processing and Storage System
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, announces that the first two patients enrolled have begun receiving transfusions in a multi-center, randomized, controlled cross-over study to evaluate the safety and effectiveness of hypoxic red blood... - December 20, 2024 - Hemanext
Elait Health Appoints Michael Boggs as New CEO to Drive Company Strategy and Adoption of Its AI-powered Health Data Management Platform
Michael Boggs brings decades of leadership experience to drive Elait Health’s strategy, expand its AI-powered health data management platform, and enhance healthcare innovation. - December 19, 2024 - Elait Health
Exquiste Estate in the Hills Above St. Helena Hits the Market
Mayacama Luxury Real Estate is proud to present a truly remarkable property: 2509 Madrona Avenue, a sophisticated estate situated in the heart of Napa Valley's wine country. This stunning residence offers the perfect blend of timeless elegance, modern luxury, and unparalleled access to the best of... - December 17, 2024 - Mayacama Luxury Real Estate
Augie’s Quest to Cure ALS Completes $5.8 Million Commitment to Fund ALS TDI’s Translational Research Center
The ALS Therapy Development Institute (ALS TDI) is proud to announce that Augie’s Quest to Cure ALS has fulfilled its $5.8 million commitment, pledged in 2021, to advance ALS research. This transformative funding has directly supported the Augie’s Quest Translational Research Center... - December 13, 2024 - ALS Therapy Development Institute
Regenexx Announces Dr. Philippe Hernigou as New Medical Director of Clinical Research
Regenexx®, a leader in regenerative medicine and advanced orthobiologics, is proud to announce that Dr. Philippe Hernigou, a globally recognized expert in autologous cell therapy and musculoskeletal regeneration, has joined the company as its new Medical Director of Clinical Research. Dr. - December 11, 2024 - Regenexx
SeroRepair Announces New Office Location to Support Expansion and Growth
SeroRepair, an eye serum leader in the veterinary industry announces expansion to a new office location for increased operations, customer service, and product development, positioning the company for continued success in the veterinary industry. With an ever-growing demand for high-quality eye care products for small and large animals and a need for increasing efficiency in veterinary practices, SeroRepair has experienced significant growth over the past year. - December 10, 2024 - SeroRepair
Arizona Pharmacy Association Appoints Garet Turner as New CEO
Today, the Arizona Pharmacy Association (AzPA), the leading voice for Arizona’s pharmacy professionals, announced the appointment of Garet Turner as its new Chief Executive Officer. Turner, a seasoned management, membership and fundraising professional will take the helm on January... - December 07, 2024 - Arizona Pharmacy Association
Activate Brain and Body to Open New Location in Indianapolis Metro area
Join Activate Brain & Body Fitness on December 5 to celebrate the grand opening of theinnovative brain gym in Fishers, IN, designed to connect physical exercise with cognitive health. The event runs from 9 AM to 7 PM, with a ribbon cutting at 9 AM. Explore dual-task exercises, enjoy refreshments, and take advantage of special pre-sale offers on training programs. Activate is redefining fitness with a focus on brain health, and this event is free and open to the public. - December 04, 2024 - Activate Brain and Body Fitness
NuSirt Health Launches LEUSIX™ Natural GLP-1 Companion Supplement on Amazon
NuSirt Health has launched its innovative dietary supplement, LEUSIX™, for weight management and cardiometabolic health on Amazon.com. - November 26, 2024 - NuSirt Sciences, Inc.
BRSi, LP Promotes Natalie Van Baale to Vice President, Chief Operating Officer
BRSi, LP proudly announces Natalie Van Baale's promotion to Vice President and COO, effective November 1, 2024. With nearly two decades at BRSi, Natalie has led Federal Operations, expanding the company’s military healthcare presence and fostering key partnerships. BRSi is a leader in healthcare revenue cycle management and software development, serving military, federal, and public healthcare providers. This promotion highlights BRSi’s dedication to leadership and client success. - November 24, 2024 - BRSi
HealthPub Publishes Comprehensive FODMAP Statistics Report
Research highlights that up to 86% of IBS sufferers experience significant symptom relief by following a low-FODMAP diet, emphasizing its effectiveness in managing bloating, abdominal pain, and irregular bowel movements. - November 23, 2024 - Healthpub
CCT Sciences Announces Partnerships with Industry Leading Federally Compliant Delta-8 Producers
In September, CCT Sciences, LLC., a global leader in cannabinoid sciences, started patent enforcement across the nation with a focus on Florida. The company persists in its efforts to help the hemp cannabinoid industry regulate itself by fostering new relationships. Through partnerships with many... - November 18, 2024 - CCT Sciences
New Audio Narration for the GMP Training
Pharma Lessons has updated another course from their portfolio with voice-over functionality. The popular Good Manufacturing Practice training now features audio narration. The updated package was again developed with the same team of professionals used for the voice-over of their GCP training. A... - November 12, 2024 - Pharma Lessons
smartDOC: Automated Content Management Now with GenAI
smartDOC – Intelligent Content Platform for Knowledge Organizations. Easily manage regulatory content with streamlined process, leverage automation and deliver faster with their enterprise document / content system. - November 11, 2024 - DDi LLC
NeuroDex Awarded Target ALS Biomarker Consortia Grant to Drive Advancements in ALS Research
NeuroDex Awarded Target ALS Biomarker Consortia Grant to Drive Advancements in ALS Research - November 09, 2024 - NeuroDex
NanoCellect Biomedical Announces Strategic Partnership with Additional Distributors Across the APAC Region
NanoCellect Biomedical, a leading provider of innovative microfluidic flow cytometry solutions, is excited to announce new strategic partnerships with additional distributors in the Asia-Pacific (APAC) region. These partnerships will further expand NanoCellect’s presence in these key markets,... - November 08, 2024 - NanoCellect Biomedical
Creative Biolabs Shines at the 2024 NIH Research Festival: Showcasing Antibody Solutions
Creative Biolabs made a splash at the 2024 NIH Research Festival, held from Sept. 23–25, as they highlighted their groundbreaking work in antibody discovery and development. - November 08, 2024 - Creative Biolabs
Life's Transformations: The Yellow Butterfly's Lupus Experience
Rosemarie K. Witter Foundation (RKW), a not-for-profit organization dedicated to promoting medical research in finding effective treatment, leading to a cure for Lupus, is thrilled to announce the upcoming original performance of The Yellow Butterfly: A Lupus Story Benefit Play. This event aims to... - November 06, 2024 - Rosemarie K. Witter Foundation, Inc.
Polar Lab Projects Redefines Laboratory Relocation Standards with Global, Single-Source Logistics Solution
Polar Lab Projects is setting a new standard in laboratory relocations and logistics, offering a single-source, seamless solution tailored to the life sciences industry worldwide. With an extensive network of industry experts, they provide unmatched service excellence, meeting clients' needs wherever they operate. - November 06, 2024 - Polar Lab Projects LLC
Synaps Dx Launches Digital Cognitive Screening and Alzheimer’s Testing with BrainCheck and Clarity Health Clinics
Synaps Dx, BrainCheck, and Clarity Health introduce an innovative online Alzheimer's and cognitive health screening tool, accessible from home. Launching in Texas, with nationwide expansion planned, this telehealth solution provides families with a convenient, reliable path to early detection during National Alzheimer’s Disease Awareness Month, reducing the need for in-office visits and empowering proactive cognitive care. - November 04, 2024 - SynapsDx
Rare Disease Foundation on the Road to Gene Therapy Brings Families to Fort Lauderdale from Around the World, November 15-17
The FOXG1 Research Foundation, the parent-led organization that is radically transforming the rare disease drug development landscape, is hosting an international conference in Fort Lauderdale from November 15-17, bringing families from across the globe together to learn about gene therapy advancements for FOXG1 syndrome. A highlight includes a presentation by 20-year-old Abraham Weitzman, who, though non-speaking, shares his lived experience using an innovative communication device. - November 04, 2024 - FOXG1 Research Foundation
GlycoMira Therapeutics Receives Key Patent for First-in-Class Oncology Therapeutic
Key patent covering GlycoMira's lead compound GM-1111 adds to the Company's already strong IP portfolio. - November 04, 2024 - GlycoMira Therapeutics, Inc.
VitaMist® New Wholesale Purchasing Service
New Wholesale Business Offering is Geared for Distributors and Retailers - November 02, 2024 - VitaMist
VITAMIST® Launches New MultiPlus Multivitamin Oral Spray
Multi-Vitamin Plus Oral Spray is a Comprehensive Blend of Essential Nutrients - November 02, 2024 - VitaMist
Hemanext Signs Agreement with Hemara Bio in the U.A.E., Marking the Initiation of Commercialization Activities in the GCC Region
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, announced that it has entered into an exclusive distribution agreement with Hemara Bio in Dubai, United Arab Emirates (UAE) to bolster its sales capabilities across the Gulf Countries strengthening its relationships with key blood centers and clinicians in the region. - October 31, 2024 - Hemanext
NuvOx Announces Two New Publications
Co-Founders, Dr. Evan Unger and Dr. Jennifer LH Johnson combine efforts to publish 2 journal articles that help explain how the NuvOx drug candidate - NanO2TM works. Artificial Cells, Nanomedicine, and Biotechnology published Dodecafluoropentane emulsion as an oxygen therapeutic, an article that... - October 31, 2024 - NuvOx Therapeutics
Novugen Pharma Malaysia Achieves Zero Form 483 Citations in Recent USFDA Audit
Novugen Pharma Sdn. Bhd. proudly announces the successful completion of recent USFDA audit, achieving zero Form 483 citations and No Action Indicated (NAI) status—the highest level of compliance for USFDA-registered manufacturing facilities. This milestone positions Novugen among a select few global companies meeting these standards and reflects the dedication of its team. - October 29, 2024 - Novugen